Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope
Open Access
- 1 January 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 21 (1), 110-116
- https://doi.org/10.1016/0735-1097(93)90724-f
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trialJournal of the American College of Cardiology, 1992
- Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.Circulation, 1991
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990
- Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic studyJournal of the American College of Cardiology, 1989
- Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown originThe American Journal of Cardiology, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.Circulation, 1986
- Evaluation of prognostic classifications for patients with syncopeAmerican Journal Of Medicine, 1985
- Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol?Circulation, 1985
- A Prospective Evaluation and Follow-up of Patients with SyncopeNew England Journal of Medicine, 1983